Skip to main content

Select Drug Profiles

Conference Highlights ADA

Blood Glucose Testing a Significant Contributor to Pharmacy Costs in Patients Using Insulin

Perspectives, Conference Highlights ADA

ADA President’s Views on Clinical Management of Type 2 Diabetes

Conference Highlights ADA

Insulin Inappropriately Discontinued in Many Type 2 Diabetes Patients After Hospitalization

Conference Highlights ADA

Type 2 Diabetes Treatment in Patients with CKD Should Conform to NKF Guidelines for Better Outcomes, Lower Costs

From Asheville to Hickory: Transforming Our “Sick Care” System into a True “Health Care” Model

Daniel G. Garrett, RPh, MS, FASHP

Original Research

The Hickory Project: Controlling Healthcare Costs and Improving Outcomes for Diabetes Using the Asheville Project Model

Barry A. Bunting, PharmD, DSNAP, Grover Lee, PharmD, BCMCM, Grant Knowles, PharmD, Christine Lee, PharmD, BCPS, CLS, Paul Allen, PhD, MBA

Stakeholder Perspective

Keeping a Lid on Health Plan Costs, One Patient at a Time

Practice Management

Health Resource Utilization and Direct Costs Associated with Angina for Patients with Coronary Artery Disease in a US Managed Care Setting

Judy Kempf, PhD, Erin Buysman, MS, Diana Brixner, RPh, PhD, Michael F. Murphy, MD, PhD

Stakeholder Perspective

Medical Claims Data Can Inform Coverage Decisions in Managed Care Health Plans

Adapting to Market Changes: Beyond Healthcare Reform

F. Randy Vogenberg, PhD, FASHP

Practice Management

Review of Strategies to Enhance Outcomes for Patients with Type 2 Diabetes: Payers’ Perspective

Rhonda Greenapple, MSPH

Stakeholder Perspective

We Must All Engage in the Diabetes Challenge: A Lifelong Journey, with No Silver Bullet

by Charles E. Collins, Jr., MS, MBA

The Era of Personalized Medicine in Oncology: Novel Biomarkers Ushering in New Approaches to Cancer Therapy

Steve Stricker, PharmD, MS, BCOP

Page 212 of 244
Results 2111 - 2120 of 2434